Your browser doesn't support javascript.
loading
Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma.
Drent, Esther; Groen, Richard W J; Noort, Willy A; Themeli, Maria; Lammerts van Bueren, Jeroen J; Parren, Paul W H I; Kuball, Jürgen; Sebestyen, Zsolt; Yuan, Huipin; de Bruijn, Joost; van de Donk, Niels W C J; Martens, Anton C M; Lokhorst, Henk M; Mutis, Tuna.
Affiliation
  • Drent E; Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands Departments of Clinical Chemistry and Hematology, Utrecht, the Netherlands.
  • Groen RW; Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands Department of Cell Biology, University Medical Center, Utrecht, the Netherlands.
  • Noort WA; Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands Department of Cell Biology, University Medical Center, Utrecht, the Netherlands.
  • Themeli M; Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands.
  • Lammerts van Bueren JJ; Genmab, Utrecht, the Netherlands.
  • Parren PW; Genmab, Utrecht, the Netherlands Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, the Netherlands.
  • Kuball J; Department of Hematology, University Medical Center, Utrecht, the Netherlands.
  • Sebestyen Z; Department of Immunology, University Medical Center Utrecht, the Netherlands.
  • Yuan H; Xpand Biotechnology BV, Bilthoven, the Netherlands.
  • de Bruijn J; Xpand Biotechnology BV, Bilthoven, the Netherlands The School of Engineering and Materials Science, Queen Mary University of London, UK.
  • van de Donk NW; Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands.
  • Martens AC; Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands Department of Cell Biology, University Medical Center, Utrecht, the Netherlands Department of Immunology, University Medical Center Utrecht, the Netherlands.
  • Lokhorst HM; Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands Department of Hematology, University Medical Center, Utrecht, the Netherlands.
  • Mutis T; Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands Departments of Clinical Chemistry and Hematology, Utrecht, the Netherlands t.mutis@vumc.nl.
Haematologica ; 101(5): 616-25, 2016 05.
Article in En | MEDLINE | ID: mdl-26858358
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Recombinant Fusion Proteins / Receptors, Antigen, T-Cell / T-Lymphocytes / ADP-ribosyl Cyclase 1 / Immunotherapy / Multiple Myeloma Limits: Animals / Humans Language: En Year: 2016 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Recombinant Fusion Proteins / Receptors, Antigen, T-Cell / T-Lymphocytes / ADP-ribosyl Cyclase 1 / Immunotherapy / Multiple Myeloma Limits: Animals / Humans Language: En Year: 2016 Type: Article